Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBM/BMP vs ICBG for Alveolar Bone Grafting in Cleft Lip and Palate
NCT04234971Phase 4Recruiting
- Sponsor
- UTHealth Houston
- Start
- Jun 2021
- Primary completion
- Jan 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dibotermin alfa in cleft lip and palate (CLP), sponsored by UTHealth Houston. Started Jun 2021; status: recruiting.
02
Drugs
dibotermin alfa
03
Conditions
cleft lip and palate (CLP)
Beyond the preview
Go deeper on NCT04234971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04234971.